Atara Biotherapeutics Inc at Cowen Health Care Conference Transcript
So we'll get things started. Welcome everyone to our cell therapy corporate panel at the 43rd Annual Healthcare Conference. I'm Ernie Rodriguez from the biotech team at TD Cowen, and I'm joined by my colleagues; Boris Peaker, Yaron Werber, and [Jenna Hahn].
And we have the pleasure today to have a great panel of representatives in the cell therapy space. We have CEO Adrian Rawcliffe from Adaptimmune; President and CEO, Pascal Touchon from Atara Biotherapeutics; President and CEO Paul Hastings from Nkarta; and President and CEO David Southwell from TScan.
Questions & Answers
So thank you very much for joining us. We are going to start the conversation with a few thematic questions on the space overall, and then we'll do a round robin between the individual companies under specific programs.
So I guess asking the panel, over the past year, year or so, we have seen a number of regulatory delays, holds, on cell therapy programs. From these
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
